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left ventricle to normal size, during which the reduction of the left
ventricular diameter exhibits benefits in recovering left ventricular
function in accordance with the concept proposed by Batista.5
The possibility of compromise ventricular stroke volume is
always present. However, if we consider the base of the papillary
muscle as a mark to limit our ventricular reduction, this risk
becomes very low, as demonstrated in the echocardiographic re-
sults of our latest patient obtained 7 months postoperatively, which
present a normal ventricular cavity and normal ventricular ejection
fraction.
Although this study involved few patients, this simple technical
variation could be used to close the ventricular septal rupture
without any residual shunt and could represent one more alterna-
tive to resolve a difficult surgical problem.
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A case of chest wall angiosarcoma associated with breast implants
Neil D. Saunders, BS, J. Stephen Marshall, MD, and Richard C. Anderson, MD, Peoria, Ill
Primary angiosarcomas of the breast or chest wall areexceedingly rare. Generally, primary sarcomas of thebreast are less than 0.1% of breast malignancies, withangiosarcomas making up between 25% and 40% of
these cases.1 Angiosarcomas tend to be aggressive, with a high rate
of local recurrence and low 5- and 10-year survival rates. Standard
treatment for breast or chest wall angiosarcoma is surgical exci-
sion, and there is no clear evidence regarding the role of adjuvant
chemotherapy or radiation.2 Both irradiation and postmastectomy
angioedema are known to substantially increase the risk for an-
giosarcoma in the breast or chest wall. However, the case we
present is primary angiosarcoma in a radiation-naive, augmented
breast.
Clinical Summary
A 58-year-old woman presented with a 4-month history of non-
productive cough and tenderness on the left side of her chest. The
patient received bilateral submuscular silicone breast implants in
1975 and had noted that recently the superior aspect of her left
breast had become larger than the right. On physical examination,
left breast asymmetry was apparent and caused by a firm nonmo-
bile mass. A computed tomographic (CT) scan showed a lobulated
mass posterior to her left breast implant measuring 5  4 cm,
eroding the third and fourth ribs and extending into the chest
(Figure 1). Moderately prominent axillary lymph nodes were also
noted. Positron emission tomographic scanning revealed no evi-
dence of spread beyond the anterior left chest wall. Fine-needle
aspiration of the mass was pankeratin positive and negative for
S100, melanin A, and HMB-45 and was concluded to be non–
small cell carcinoma.
A wide en bloc excision of the left breast with chest wall and
ribs was performed. The tumor was adherent to the pectoralis
major and the chest wall (Figure 2). The pectoralis major was
removed from the shoulder and clavicle, and the ribs were divided
at the sternum. Axillary lymph nodes were removed as well, and
the chest wall was reconstructed with a polytetrafluoroethylene*
patch. Surgical pathology revealed an epithelioid angiosarcoma
staining positive for vimentin, Factor VIII, pankeratin antibody,
and CD34. Margins were negative, and no penetration of the
pleural space was seen. All 15 of the removed axillary lymph
nodes were also negative for primary or metastatic malignancy.
The patient did well after the operation and was discharged with a
good prognosis.
Five months later, the patient presented with severe anemia and
hemoptysis caused by bilateral recurrence of the angiosarcoma. CT
of the thorax revealed a 3 3.6–cm mass in the left anterior chest
at the level of the aortic arch and bilateral metastatic lung nodules.
A left thoracotomy with multiple wedge resection was performed,
and the lateral chest wall was further resected. Postoperatively, the
patient experienced respiratory failure caused by pneumonia and
required mechanical ventilation for 4 weeks. Resection of the right
side was unable to be performed. Two months after the second
resection, she presented with chest fullness in the left breast area,
and a CT scan showed a 10  6–cm left chest wall mass with
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extensive left lung nodules. Chemotherapy with paclitaxel (Taxol)
was initiated; however, the patient died 16 months later.
Discussion
For the past 60 years, it has been known that implanted materials
can induce inflammation, blood vessel proliferation, and the even-
tual development of angiosarcoma. In addition to those in animal
models, there have been around a dozen cases of angiosarcoma
associated with implanted foreign materials, including Dacron
aortic grafts, dialysis shunts, and orthopedic implants.3 Common-
alities among them are long latency periods and high grades at
presentation, which is consistent with our case.
Multiple cohort and case-control studies of women with sili-
cone breast implants have shown that implants do not increase
one’s overall cancer risk, and in many studies the breast cancer rate
among women with breast implants is actually lower because of
lifestyle variables in women who seek cosmetic surgery.4 The
types of cancers, sarcoma versus carcinoma, are not broken down
in these cohorts, and therefore it is impossible to conclude whether
there is an increase in a particular type of cancer. Analysis of the
Surveillance Epidemiology and End Results (SEER) data between
1973 and 1990 showed no increase in angiosarcoma in women;
however, these data included all women and not just women who
received silicone breast implants.5
The rarity of primary angiosarcoma suggests that even if there
was a multifold increase in this cancer among women with breast
implants, the resulting data would not have enough power to show
a statistically significant change. The miniscule incidence of this
particular cancer, including a possible increase caused by im-
planted materials, would not affect overall breast cancer rates but
is a complication of which clinicians should be aware.
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Figure 1. Chest CT scan showing a mass beneath the left breast
implant.
Figure 2. Gross specimen showing implant and angiosarcoma.
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